NCT01100645Unknown3 期
Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological Insomnia
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Improvement in sleep efficiency
研究概览
简要总结
The main objective of this study is to evaluate the clinical efficacy of the drug Sominex (Valeriana officinalis L., 40 mg, 30 mg Crataegus oxyacantha L. and Passiflora incarnata L. 50 mg) manufactured by the Laboratory EMS S / A, compared to placebo in improving sleep efficiency, based on the response of the sleep quality questionnaire (MSQ) and polysomnographic parameters described below:
- Latency to onset of sleep;
- Total time of sleep;
- Rapid eye movement (REM) sleep latency;
- Duration of REM sleep
详细描述
Verify the effectiveness of the drug Sominex compared to placebo based on the improvement of the following parameters measured by the following validated scales:
- Anxiety;
- Daytime sleepiness; Will also be assessed secondary to drug safety testing for the occurrence, type, frequency and intensity of adverse events during treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who agree and sign the informed consent form (ICF);
- •Adult patients, aged ≥ 18 years and ≤ 65 years, male or female;
- •Patients who agree to perform all study procedures;
- •Patients diagnosed with psychophysiological insomnia;
- •Patients who present in the application of sleep questionnaire result ≥ 25 and ≤ 30 points;
- •Patients presenting in polysomnography change in any of the polysomnographic parameters than the normal range.
排除标准
- •Having participated in any experimental study or have ingested any drug trial within 12 months prior to the start of the study;
- •Be in use or have used other medications that interfere with the regular response of the drug at least 04 weeks prior to the start of the study, as benzodiazeínicos, antidepressants with sedative, sedatives, antihistamines and other herbal medicines;
- •Being in treating or have been treated with alternative methods that interfere with the drug response to at least 04 weeks prior to the start of the study, such as behavioral therapies and relaxation techniques, such as yoga, massage, etc.;
- •Be patient with sensitivity to an association of herbal medicines;
- •Present history of alcohol abuse, drugs or medicines;
- •Pregnant or nursing women;
- •Owning a history of liver disease or renal impairment and / or thyroid dysfunction;
- •Patients with a history of restless sleep: nocturnal myoclonus or restless legs syndrome;
- •Patients with a history of snoring or bruxism exaggerated;
- •Diseases that affect sleep, causing pain or immobilization of the patient in bed;
- •Patients who have extensive work or working in night shifts totally or partially nocturnal;
- •Patients in whom polysomnography demonstrating non-characteristic changes in sleep disturbances of psychophysiological origin as narcolepsy, hipopinéia syndrome, upper airway hypersensitivity syndrome of periodic limb movements, sleepwalking, among others;
- •Physical or psychological disorders that might interfere with the analysis of data such as neurosis, depression, muscle atrophy, and / or staying the medical criteria.
研究组 & 干预措施
Test
Experimental
Sominex ® (Passiflora incarnata L. 50 mg, Valeriana officinalis L. 40 mg and Crataegus oxyacantha L. 30 mg)
干预措施: Sominex (Drug)
Placebo
Placebo Comparator
Excipient
干预措施: Placebo (Drug)
结局指标
主要结局
Improvement in sleep efficiency
时间窗: 28 days of treatment.
Quality of Sleep Questionnaire and the polysomnographic parameters: * Latency to onset of sleep; * Total time of sleep; * REM sleep latency; * Duration of REM sleep;
次要结局
- Improvement of the values obtained by the answers of the questionnaires obtained during the treatment(28 days of treatment.)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin LymphomaT Cell LymphomaLymphomaDLBCLNCT05852028Ruijin Hospital250
终止
不适用
Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV StatusPlasmodium Falciparum MalariaNCT00304980Institute of Tropical Medicine, Belgium3,000
终止
2 期
STEPS Trial - Spheramine Safety and Efficacy StudyParkinson DiseaseNCT00206687Bayer71
终止
不适用
Evaluation of the Safety of the Medical Device Simeox®Broncho-degenerative DiseaseChronic Obstructive Airway DiseaseCystic FibrosisIdiopathic BronchiectasisCiliary DyskinesiaChronic BronchitisNCT02061852Physio-Assist15
已完成
4 期
Evaluation of the Efficacy and Safety of Herbal Medicine for Treating Work-related Chronic Low Back PainLow Back PainWorkplaceNCT02988232Gachon University Gil Oriental Medical Hospital72